Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0R8LV
|
|||
| Former ID |
DIB011228
|
|||
| Drug Name |
NI-0401
|
|||
| Synonyms |
Anti-CD3 antibody, NovImmune/Merck Serono
Click to Show/Hide
|
|||
| Drug Type |
Antibody
|
|||
| Indication | Autoimmune diabetes [ICD-11: 5A10] | Phase 1/2 | [1] | |
| Company |
NovImmune
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Regulatory protein unspecific (RGP) | Target Info | . | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00805909) NI-0401 in Patients With Acute Renal Allograft Rejection. U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of NovImmune. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.